Left ventricular dysfunction associated with axitinib and nivolumab experience in an advanced renal cell carcinoma.
Ozgur TanrıverdiSedef AtesKerim K SandalSelcuk UylasIslam C BosnaAli AlkanPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)
We have limited no data about cardiotoxicity associated axitinib and limited data about ICIPs. Our case is unique by providing data about how to manage a metastatic RCC patient with left ventricular dysfunction under axitinib and how to follow-up the cardiac functions while under nivolumab therapy.
Keyphrases
- left ventricular
- renal cell carcinoma
- electronic health record
- big data
- heart failure
- metastatic renal cell carcinoma
- acute myocardial infarction
- small cell lung cancer
- squamous cell carcinoma
- cardiac resynchronization therapy
- mitral valve
- left atrial
- stem cells
- machine learning
- coronary artery disease
- atrial fibrillation
- deep learning
- bone marrow
- aortic valve